KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
110 허원도 교수와 양희원, 최하나 학생 Freshman Design Course에서 최우수상 수상! 과사무실 2009.09.07 15144
109 이규리 학생(박태관 교수님 Lab), ICMAT 2009 & IUMRS-ICA 2009 Best Poster Award 수상 과사무실 2009.07.13 13453
108 김진우 교수, 교과부 '글로벌연구실 사업'의 신규 지원과제에 선정! 과사무실 2009.06.25 13035
107 우주연 학생(김은준 교수님 Lab), 로레알-유네스코 펠로쉽 수상 과사무실 2009.06.23 17460
106 박태관 교수, "암 진단에서 치료ㆍ촬영까지 한꺼번에" 과사무실 2009.05.12 12339
105 최길주 교수, PNAS(P Natl Acad Sci USA) 4월호에 논문 게재 과사무실 2009.04.23 14796
104 Raghu P. Kataru(고규영 교수님 Lab), Blood 지 게재 승인 과사무실 2009.04.06 12717
103 김은준 교수, 뇌 속 시냅스 생성 단백질 발견 과사무실 2009.04.06 11423
102 박태관 교수, 미국생체재료학회 클렘슨상 수상! 과사무실 2009.04.02 11265
101 최길주 교수, Plant Cell 2월호에 논문 게재 과사무실 2009.04.02 14992
100 2009년 개교 38주년 기념 우수교원 포상 과사무실 2009.02.17 11310
99 학사과정 김유나 학생, 2008학년도 인성장학생으로 선정! 과사무실 2008.12.09 15003
98 김진우 교수, 노인성 망막퇴행질환 핵심 단백질 찾았다 과사무실 2008.11.18 12460
97 최길주 교수, 제5회 마크로젠 신진과학자상 수상 과사무실 2008.10.13 11758
96 바이오칩 저널(학회장 김학성 교수) SCIE 공식 등재 과사무실 2008.09.29 12236
95 생명과학과 <b>정종경 교수</b>, 경암학술상 수상! 과사무실 2008.09.23 15474
94 2단계 BK21 <b>2년 연속 생물분야 1위!</b> 과사무실 2008.09.10 11359
93 생명과학과 박태관 교수, 새로운 항암유전자 전달시스템 개발 과사무실 2008.07.08 15038
92 생명과학과 김재섭 교수, ‘동물 체온의 비밀’ 열쇠 찾아 과사무실 2008.07.03 12254
91 생명과학과 박태관 교수, 두 저널에 표지논문으로 게재 과사무실 2008.06.25 11434
Board Pagination Prev 1 ... 12 13 14 15 16 17 18 19 20 21 22 Next
/ 22